Characteristicsa | NLR < 3.94/ UA < 313.00 µmol/L | NLR < 3.94/ UA ≥ 313.00 µmol/L | NLR ≥ 3.94/ UA < 313.00 µmol/L | NLR ≥ 3.94/ UA ≥ 313.00 µmol/L | P value |
---|---|---|---|---|---|
Patients, n | 139 | 139 | 138 | 139 | |
Age, y | 64.02 ± 11.94 | 63.61 ± 12.58 | 66.62 ± 12.45 | 67.35 ± 12.75 | 0.026 |
Male sex, n (%) | 71(51.08) | 105(75.54) | 74(53.62) | 103(74.10) | < 0.001 |
Current cigarette smoking, n (%) | 42(30.22) | 66(47.48) | 40(28.99) | 55(39.57) | 0.004 |
Current alcohol drinking, n (%) | 29(20.86) | 31(22.30) | 19(13.77) | 23(16.65) | 0.234 |
Time from onset to thrombolysis, h | 3.00(2.62–3.70) | 3.00(2.33–3.97) | 3.33(2.67-4.00) | 3.38(2.67-4.00) | 0.081 |
Admission systolic BP, mm Hg | 147.60 ± 19.10 | 147.27 ± 18.21 | 154.36 ± 23.36 | 148.44 ± 22.35 | 0.015 |
Admission diastolic BP, mm Hg | 81.95 ± 12.83 | 82.24 ± 13.48 | 82.36 ± 15.15 | 83.78 ± 15.24 | 0.718 |
Triglycerides, mmol/L | 1.07(0.85–1.44) | 1.21(0.92–1.80) | 1.09(0.79–1.38) | 1.09(0.80–1.45) | 0.014 |
Total cholesterol, mmol/L | 4.54(3.89–5.27) | 4.86(4.23–5.51) | 4.52(3.81–5.22) | 4.41(3.88–5.11) | 0.008 |
LDL cholesterol, mmol/L | 2.88(2.15–3.34) | 3.04(2.47–3.65) | 2.78(2.20–3.21) | 2.70(2.22–3.27) | 0.006 |
HDL cholesterol, mmol/L | 1.16(0.95–1.38) | 1.12(0.94–1.33) | 1.21(1.02–1.50) | 1.17(1.00-1.35) | 0.049 |
Plasma glucose, mmol/L | 6.70(5.60–8.60) | 6.70(5.40–8.20) | 7.35(6.40–9.30) | 7.10(5.90–8.90) | < 0.001 |
Admission NIHSS score | 8(4–12) | 8(5–12) | 12(7–18) | 14(9–19) | < 0.001 |
Admission mRS score | 4(3–5) | 4(3–5) | 5(4–5) | 5(4–5) | < 0.001 |
History of hypertension, n (%) | 99(71.22) | 101(72.66) | 111(80.43) | 115(82.73) | 0.058 |
History of hyperlipidemia, n (%) | 58(41.73) | 62(44.60) | 40(28.99) | 41(29.50) | 0.008 |
History of diabetes mellitus, n (%) | 26(18.71) | 18(12.95) | 31(22.46) | 22(15.83) | 0.190 |
History of stroke, n (%) | 19(13.67) | 22(15.83) | 26(18.84) | 25(17.99) | 0.656 |
History of coronary heart disease, n (%) | 6(4.32) | 4(2.88) | 5(3.62) | 8(5.76) | 0.665 |
History of atrial fibrillation, n (%) | 34(24.46) | 38(27.34) | 51(36.96) | 76(54.68) | < 0.001 |
Use of antihypertensive medications, n (%) | 8(5.76) | 10(7.19) | 10(7.25) | 16(11.51) | 0.316 |
Stroke subtypes (TOAST) | < 0.001 | ||||
Large artery atherosclerosis | 69(49.64) | 66(47.48) | 52(37.68) | 45(32.37) | |
Small vessel occlusion | 35(25.18) | 37(26.62) | 55(39.86) | 76(54.68) | |
Cardioembolism | 28(20.14) | 34(24.46) | 21(15.22) | 10(7.19) | |
Stroke of other determined etiology | 5(3.60) | 0(0.00) | 7(5.07) | 6(4.32) | |
Stroke of undetermined etiology | 2(1.44) | 2(1.44) | 3(2.17) | 2(1.44) |